Engineering Hyperechogenic Colloids with Clot-Targeting Capabilities from Platelet-Derived Membranes.
Ontology highlight
ABSTRACT: Thrombosis-related cardiovascular diseases remain the leading global cause of mortality and morbidity. In this study, we present a pioneering approach in the field of nanobiotechnology, with a focus on clinical translation, aimed at advancing early diagnosis and enhancing treatment options for thrombotic disorders. We introduce the fabrication of Platelet Membrane-Derived Bubbles (PMBs), which exhibit distinctive characteristics compared to conventional nanoparticles. These PMBs possess an average diameter of 700 nm and a negative ζ-potential, mirroring the attributes of parent platelet membranes. Utilizing diagnostic ultrasound imaging, we demonstrated the ability to visualize PMBs as hyperechogenic entities in agarose phantoms in vitro and in live mice in vivo. Furthermore,
SUBMITTER: Vidallon MLP
PROVIDER: S-EPMC11492166 | biostudies-literature | 2024 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA